Aktuellt
SENASTE
The Q1 results showed continuation of recent strong trends (sales growth of 17% y/y). In our view, SyntheticMR has begun 2021 with newfound confidence and we see several levers of growth throughout the year. Our estimates are broadly unchanged following the Q1 results, which were in line with expectations. Our DCF-based fair value range of SEK 424-559 per share is unchanged.
LÄS MER
